Evidence map›Paper›PMID 41982371›Full record

ArticleCureus2026

Spontaneous Auto-Amputation of the Breast in a Patient With Advanced Malignant Fungating Wound and Distant Metastases Involving the Lungs and Left Upper Extremity: A Case Report.

Emilia Piaszczynska, Oktawia Pylak-Piwko

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emilia PiaszczynskaFaculty of Medicine, Medical University of Lublin, Lublin, POL.
Oktawia Pylak-PiwkoUnit of Palliative Medicine, Faculty of Health, Medical University of Lublin, Lublin, POL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant fungating wounds in advanced breast cancer cause significant morbidity and psychological distress. Spontaneous auto-amputation of the breast is a rare clinical phenomenon, conventionally linked to neglected tumors rather than actively treated disease. We present a case of spontaneous auto-amputation in an extensively pretreated 60-year-old female with advanced human epidermal growth factor receptor 2-positive (HER2+) breast cancer. She presented to the palliative care unit with refractory left upper extremity pain, severe tactile and thermal allodynia due to malignant brachial plexopathy, and extensive malignant lymphedema complicated by deep vein thrombosis. During her clinical course, despite prior multi-line systemic therapy, rapid local tumor proliferation outpaced neovascularization, leading to critical ischemia, extensive necrosis, and the culminating spontaneous auto-amputation of her left breast. Symptom control required an escalation of pharmacological therapy beyond standard opioid protocols due to inadequate efficacy. To manage the refractory neuropathic pain, the regimen was supplemented with advanced intravenous adjuvant analgesia, bypassing the traditional three-step World Health Organization analgesic ladder. This utilized targeted infusions of lidocaine, magnesium sulfate, and dexmedetomidine. Ultimately, the patient's progressive condition necessitated the implementation of palliative analgosedation to manage refractory distress and maintain dignity. This case highlights that effective advanced management requires dynamic, multimodal palliative strategies, prioritizing the early recognition of complex neuropathic mechanisms and the utilization of advanced intravenous interventions.

Indexed as

auto-amputationbreast cancerfungating malignant woundneuropathic painpalliative care

Identifiers

PMID41982371
PMCPMC13071299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.